[
  {
    "ts": null,
    "headline": "Will Keytruda Continue to Aid MRK's Top Line Ahead of Q2 Earnings?",
    "summary": "Merck's Keytruda drives nearly half of its pharma sales. Investors eye Q2 momentum amid existing competition.",
    "url": "https://finnhub.io/api/news?id=b014c41bc7930cd958e99b1a89cdbde7dc31a5a891f44d9b6910fcf65d820749",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753280700,
      "headline": "Will Keytruda Continue to Aid MRK's Top Line Ahead of Q2 Earnings?",
      "id": 136062252,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck's Keytruda drives nearly half of its pharma sales. Investors eye Q2 momentum amid existing competition.",
      "url": "https://finnhub.io/api/news?id=b014c41bc7930cd958e99b1a89cdbde7dc31a5a891f44d9b6910fcf65d820749"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Dow Rises 250 Points On Trump Trade Deal; Nvidia Rallies (Live Coverage)",
    "summary": "The Dow Jones Industrial Average and other major stock indexes traded higher Wednesday, as Wall Street cheered President Donald Trump's announcement of a trade deal with Japan. Artificial intelligence giant Nvidia was one of the early winners on the stock market today.",
    "url": "https://finnhub.io/api/news?id=04968b4dcb2b2e68cc215c2485b072125e470f448720f54c15eefedc369dd7cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753278045,
      "headline": "Stock Market Today: Dow Rises 250 Points On Trump Trade Deal; Nvidia Rallies (Live Coverage)",
      "id": 136043980,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The Dow Jones Industrial Average and other major stock indexes traded higher Wednesday, as Wall Street cheered President Donald Trump's announcement of a trade deal with Japan. Artificial intelligence giant Nvidia was one of the early winners on the stock market today.",
      "url": "https://finnhub.io/api/news?id=04968b4dcb2b2e68cc215c2485b072125e470f448720f54c15eefedc369dd7cb"
    }
  },
  {
    "ts": null,
    "headline": "Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results",
    "summary": "Shares of Abivax hit the stratosphere Wednesday after the firm unveiled \"potentially disruptive\" results for its ulcerative colitis drug.",
    "url": "https://finnhub.io/api/news?id=740c5c3502a0118d2c436b26dd81a40b6f26e2b2e383432128c1d36022ac9e97",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753276507,
      "headline": "Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results",
      "id": 136044154,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Shares of Abivax hit the stratosphere Wednesday after the firm unveiled \"potentially disruptive\" results for its ulcerative colitis drug.",
      "url": "https://finnhub.io/api/news?id=740c5c3502a0118d2c436b26dd81a40b6f26e2b2e383432128c1d36022ac9e97"
    }
  },
  {
    "ts": null,
    "headline": "Caterpillar, Merck share gains lead Dow's 384-point climb",
    "summary": "Caterpillar, Merck share gains lead Dow's 384-point climb",
    "url": "https://finnhub.io/api/news?id=bfee5708565b43440eab6d6913457dbcd2ac984ba8500b764643f4ad2be46d21",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753271760,
      "headline": "Caterpillar, Merck share gains lead Dow's 384-point climb",
      "id": 136069995,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Caterpillar, Merck share gains lead Dow's 384-point climb",
      "url": "https://finnhub.io/api/news?id=bfee5708565b43440eab6d6913457dbcd2ac984ba8500b764643f4ad2be46d21"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Small Cap Strategy Q2 2025 Commentary",
    "summary": "The Strategy underperformed its benchmark as detractors in the consumer discretionary and communication services sector overcame positive contributions from the utilities sector.",
    "url": "https://finnhub.io/api/news?id=12dde8747587ddc6f5e5669d051e81ad924891af7362f50c04eaf040191cf234",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753264200,
      "headline": "ClearBridge Small Cap Strategy Q2 2025 Commentary",
      "id": 136043972,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1256967959/image_1256967959.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "The Strategy underperformed its benchmark as detractors in the consumer discretionary and communication services sector overcame positive contributions from the utilities sector.",
      "url": "https://finnhub.io/api/news?id=12dde8747587ddc6f5e5669d051e81ad924891af7362f50c04eaf040191cf234"
    }
  },
  {
    "ts": null,
    "headline": "Dow up 200 points on gains for shares of Caterpillar, Merck",
    "summary": "Dow up 200 points on gains for shares of Caterpillar, Merck",
    "url": "https://finnhub.io/api/news?id=da446bdea3056cc8d9f55af9a0d0eeb4671d1ebbd326973604ddf554d564fb06",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753263900,
      "headline": "Dow up 200 points on gains for shares of Caterpillar, Merck",
      "id": 136069511,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Dow up 200 points on gains for shares of Caterpillar, Merck",
      "url": "https://finnhub.io/api/news?id=da446bdea3056cc8d9f55af9a0d0eeb4671d1ebbd326973604ddf554d564fb06"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Building The Next Oncology Empire",
    "summary": "Pfizer: Building The Next Oncology Empire",
    "url": "https://finnhub.io/api/news?id=cf0b9c6bb908568b634a846b27c713d1dd35f1e483850eb53c06ab71113c9132",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753243977,
      "headline": "Pfizer: Building The Next Oncology Empire",
      "id": 136039403,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=cf0b9c6bb908568b634a846b27c713d1dd35f1e483850eb53c06ab71113c9132"
    }
  }
]